Search Results - "Sutter, Roland W. "

Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle-Free Device in Cuba by Resik, Sonia, Tejeda, Alina, Mas Lago, Pedro, Diaz, Manuel, Carmenates, Ania, Sarmiento, Luis, Alemañi, Nilda, Galindo, Belkis, Burton, Anthony, Friede, Martin, Landaverde, Mauricio, Sutter, Roland W.

“…Background. As part of an evaluation of strategies to make inactivated poliovirus vaccine (IPV) affordable for developing countries, we conducted a clinical…”
Get full text

Efficacy of inactivated poliovirus vaccine in India by Jafari, Hamid, Deshpande, Jagadish M., Sutter, Roland W., Bahl, Sunil, Verma, Harish, Ahmad, Mohammad, Kunwar, Abhishek, Vishwakarma, Rakesh, Agarwal, Ashutosh, Jain, Shilpi, Estivariz, Concepcion, Sethi, Raman, Molodecky, Natalie A., Grassly, Nicholas C., Pallansch, Mark A., Chatterjee, Arani, Aylward, R. Bruce

“…Inactivated poliovirus vaccine (IPV) is efficacious against paralytic disease, but its effect on mucosal immunity is debated. We assessed the efficacy of IPV…”
Get full text

Priming after a Fractional Dose of Inactivated Poliovirus Vaccine by Resik, Sonia, Tejeda, Alina, Sutter, Roland W, Diaz, Manuel, Sarmiento, Luis, Alemañi, Nilda, Garcia, Gloria, Fonseca, Magilé, Hung, Lai Heng, Kahn, Anna-Lea, Burton, Anthony, Landaverde, J. Mauricio, Aylward, R. Bruce

“…Post-polio eradication planning is under way. In this randomized trial, a fractional dose (one fifth) of the inactivated polio vaccine given intradermally in…”
Get full text

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014-2017 by Grassly, Nicholas C, Wadood, Mufti Zubair, Safdar, Rana M, Mahamud, Abdirahman Sheikh, Sutter, Roland W

“…Pakistan began using inactivated poliovirus vaccine alongside oral vaccine in mass campaigns to accelerate eradication of wild-type poliovirus in 2014. Using…”
Get full text

Development of inactivated poliovirus vaccine from Sabin strains: A progress report by Okayasu, Hiromasa, Sein, Carolyn, Hamidi, Ahd, Bakker, Wilfried A.M., Sutter, Roland W.

“…The Global Polio Eradication Initiative (GPEI) has seen significant progress since it began in 1988, largely due to the worldwide use of oral poliovirus…”
Get full text

Vaccine-derived polioviruses and the endgame strategy for global polio eradication by KEW, Olen M, SUTTER, Roland W, DE GOURVILLE, Esther M, DUWDLE, Walter R, PALLANSCH, Mark A

“…As the global eradication of wild poliovirus nears, the World Health Organization (WHO) is addressing challenges unprecedented in public health. The live,…”
Get full text

Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era by Bandyopadhyay, Ananda S, Singh, Harpal, Fournier-Caruana, Jacqueline, Modlin, John F, Wenger, Jay, Partridge, Jeffrey, Sutter, Roland W, Zaffran, Michel J

“…The Global Polio Eradication Initiative continues to make progress toward the eradication target. Indigenous wild poliovirus (WPV) type 2 was last detected in…”
Get full text

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016 by Shirreff, George, Wadood, Mufti Zubair, Vaz, Rui Gama, Sutter, Roland W, Grassly, Nicholas C

“…In 2014, inactivated poliovirus vaccine (IPV) campaigns were implemented in Nigeria and Pakistan after clinical trials showed that IPV boosts intestinal…”
Get full text

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial by Sutter, Roland W, Dr, John, T Jacob, Prof, Jain, Hemant, Prof, Agarkhedkar, Sharad, Prof, Ramanan, Padmasani Venkat, Prof, Verma, Harish, MB, Deshpande, Jagadish, PhD, Singh, Ajit Pal, MB, Sreevatsava, Meghana, MPH, Malankar, Pradeep, MD, Burton, Anthony, Chatterjee, Arani, MB, Jafari, Hamid, MD, Aylward, R Bruce, MD

“…Summary Background Poliovirus types 1 and 3 co-circulate in poliomyelitis-endemic countries. We aimed to assess the immunogenicity of a novel bivalent types 1…”
Get full text

New Strategies for the Elimination of Polio from India by Grassly, Nicholas C., Fraser, Christophe, Wenger, Jay, Deshpande, Jagadish M., Sutter, Roland W., Heymann, David L., Aylward, R. Bruce

“…The feasibility of global polio eradication is being questioned as a result of continued transmission in a few localities that act as sources for outbreaks…”
Get full text

Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial by Sutter, Roland W, Dr, Bahl, Sunil, MD, Deshpande, Jagadish M, PhD, Verma, Harish, MBBS, Ahmad, Mohammad, MD, Venugopal, P, Prof, Rao, J Venkateswara, Prof, Agarkhedkar, Sharad, Prof, Lalwani, Sanjay K, Prof, Kunwar, Abhishek, MD, Sethi, Raman, MSc, Takane, Marina, MSc, Mohanty, Lalitendu, MBBS, Chatterjee, Arani, MBBS, John, T Jacob, FRCP, Jafari, Hamid, MBBS, Aylward, R Bruce, MD

“…Summary Background Polio eradication needs a new routine immunisation schedule—three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV)…”
Get full text

Fractional Doses of Inactivated Poliovirus Vaccine in Oman by Mohammed, Ali Jafer, AlAwaidy, Salah, Bawikar, Shyam, Kurup, Padmamohan J, Elamir, Emadaldin, Shaban, Mahmoud M.A, Sharif, Sharif M, van der Avoort, Harrie G.A.M, Pallansch, Mark A, Malankar, Pradeep, Burton, Anthony, Sreevatsava, Meghana, Sutter, Roland W

“…Determining an economically sustainable way to deliver the poliovirus vaccine remains a challenge and a priority. In this article, investigators in Oman show…”
Get full text

Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in Vietnam by Huyen, Dang Thi Thanh, Mach, Ondrej, Thanh Trung, Nguyen, Thai, Pham Quang, Thang, Ho Vinh, Weldon, William C, Oberste, M Steven, Jeyaseelan, Visalakshi, Sutter, Roland W, Anh, Dang Duc

“…Due to global shortage of inactivated poliovirus vaccine and withdrawal of oral vaccine containing poliovirus type 2 (PV2), a PV2-containing vaccine was not…”
Get full text

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance by Sutter, Roland W, Eisenhawer, Martin, Molodecky, Natalia A, Verma, Harish, Okayasu, Hiromasa

“…Inactivated poliovirus vaccine (IPV), available since 1955, became the first vaccine to be used to protect against poliomyelitis. While the immunogenicity of…”
Get full text

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study by Grassly, Nicholas C, Dr, Wenger, Jay, MD, Durrani, Sunita, BSc, Bahl, Sunil, MD, Deshpande, Jagadish M, PhD, Sutter, Roland W, MD, Heymann, David L, MD, Aylward, R Bruce, MD

“…Summary Background A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the…”
Get full text

Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication by Aghamohammadi, Asghar, Abolhassani, Hassan, Kutukculer, Necil, Wassilak, Steve G, Pallansch, Mark A, Kluglein, Samantha, Quinn, Jessica, Sutter, Roland W, Wang, Xiaochuan, Sanal, Ozden, Latysheva, Tatiana, Ikinciogullari, Aydan, Bernatowska, Ewa, Tuzankina, Irina A, Costa-Carvalho, Beatriz T, Franco, Jose Luis, Somech, Raz, Karakoc-Aydiner, Elif, Singh, Surjit, Bezrodnik, Liliana, Espinosa-Rosales, Francisco J, Shcherbina, Anna, Lau, Yu-Lung, Nonoyama, Shigeaki, Modell, Fred, Modell, Vicki, Barbouche, Mohamed-Ridha, McKinlay, Mark A

“…Immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) have been isolated from primary immunodeficiency (PID) patients exposed to oral poliovirus…”
Get full text

Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial by Estívariz, Concepción F, Dr, Jafari, Hamid, MD, Sutter, Roland W, MD, John, T Jacob, Prof, Jain, Vibhor, MBBS, Agarwal, Ashutosh, MBBS, Verma, Harish, MBBS, Pallansch, Mark A, PhD, Singh, Ajit P, MBBS, Guirguis, Sherine, MA, Awale, Jitendra, MSW, Burton, Anthony, BS, Bahl, Sunil, MD, Chatterjee, Arani, MBBS, Aylward, R Bruce, MD

“…Summary Background The continued presence of polio in northern India poses challenges to the interruption of wild poliovirus transmission and the management of…”
Get full text

Mucosal Immunity after Vaccination with Monovalent and Trivalent Oral Poliovirus Vaccine in India by Grassly, Nicholas C., Jafari, Hamid, Bahl, Sunil, Durrani, Sunita, Wenger, Jay, Sutter, Roland W., Aylward, R. Bruce

“…BackgroundPersistent wild-poliovirus transmission, particularly in India, has raised questions about the degree of mucosal immunity induced by oral poliovirus…”
Get full text

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry by Macklin, Grace, Liao, Yi, Takane, Marina, Dooling, Kathleen, Gilmour, Stuart, Mach, Ondrej, Kew, Olen M, Sutter, Roland W

“…Individuals with primary immunodeficiency disorder may excrete poliovirus for extended periods and will constitute the only remaining reservoir of virus after…”
Get full text

Detection of diphtheritic polyneuropathy by acute flaccid paralysis surveillance, India by Mateen, Farrah J, Bahl, Sunil, Khera, Ajay, Sutter, Roland W

“…Diphtheritic polyneuropathy is a vaccine-preventable illness caused by exotoxin-producing strains of Corynebacterium diphtheriae. We present a retrospective…”
Get full text